Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis

Published:2017-04 Issue: Volume:32 Page:130-134
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Song Jun-Long,Chen Chuang,Yuan Jing-Ping,Li Juan-Juan,Sun Sheng-Rong

Funder

National Science Foundation of China

National Key Scientific Instrument and Equipment Development Project

Natural Science Foundation of Hubei Province, China

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference26 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Breast cancer statistics, 2015: convergence of incidence rates between black and white women;DeSantis;CA Cancer J Clin,2016

3. Family history and the risk of breast cancer: a systematic review and meta-analysis;Pharoah;Int J Cancer,1997

4. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk;Hemminki;Cancer Res,2007

5. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma;Shahedi;Cancer,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer;Journal of Clinical Medicine;2023-03-13

2. Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials;EClinicalMedicine;2021-08

3. Correlation between family history and characteristics of breast cancer;Scientific Reports;2021-03-18

4. Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study;OncoImmunology;2020-01-01

5. Métastases génitales du cancer du sein: étude de 3 cas et revue de la littérature;Pan African Medical Journal;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3